This inventor holds 1 USPTO granted patent. Top assignees: Chemo Research, S.l., Universidad Nacional De Quilmes. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 13 
1 out of 7 Years Active: 2017
Title: Pablo Lorenzano Menna: Innovator in Cancer Treatment
Introduction
Pablo Lorenzano Menna is a notable inventor based in Buenos Aires, Argentina. He has made significant contributions to the field of cancer treatment through his innovative research and development of pharmaceutical compounds.
Latest Patents
Pablo holds a patent for phenyl-guanidine derivatives. This patent provides phenyl-guanidine derivatives for the inhibition of Rac1, which blocks its interaction with guanosine exchange factors (GEFs) belonging to the DBL family. These compounds are aimed at treating aggressive and/or resistant tumors, along with pharmaceutical compositions that include them, their therapeutic uses, and processes for their preparation.
Career Highlights
Throughout his career, Pablo has worked with esteemed institutions such as Universidad Nacional De Quilmes and Chemo Research, S.L. His work has focused on developing innovative solutions for complex medical challenges, particularly in oncology.
Collaborations
Pablo has collaborated with notable individuals in his field, including Daniel Fernando Alonso and Daniel Eduardo Gómez. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Pablo Lorenzano Menna is a distinguished inventor whose work in developing phenyl-guanidine derivatives showcases his commitment to advancing cancer treatment. His contributions to the field are invaluable and reflect his dedication to improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile